 Law.com FTC Sues to Block Merger of Rivals Developing Treatment for Faulty Aortic Valves
2025-08-07 05:55 UTC by Law.comMichael Gennarohttps://feeds.feedblitz.com/-/922871018/0/law/legal-news.jpgAntitrust/General Counsel and In House Counsel/Litigation/Risk and Compliance/Southern California/Health Care/NewsA year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing Edwards Lifesciences to buy JenaValve would reduce that number to one. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. | 
